Abeona’s gene therapy candidate for Sanfilippo B shows encouraging effect in first patient; shares up 12% – Seeking Alpha
|
Abeona's gene therapy candidate for Sanfilippo B shows encouraging effect in first patient; shares up 12%
Seeking Alpha Abeona Therapeutics (ABEO +11.6%) is up on modestly higher volume in response to its announcement of encouraging data from the first MPS IIIB (Sanfilippo syndrome type B) patient treated with gene therapy candidate ABO-101. MPS IIIB … Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical Trial Why Abeona Therapeutics Jumped 14% on Wednesday Maxim Group Assigns a Buy Rating on Abeona Therapeutics |
